M. Le Liepvre, J. Ollivier, D. J. Aitken
FULL PAPER
cedure A, flash chromatography (CH2Cl2/MeOH, 98:2) gave an in-
separable mixture of bicyclic products exo-5d and endo-6d as a col-
orless oil (49%; dr 60:40, by 1H NMR). 1H NMR (360 MHz,
CDCl3): δ = 5.21 (dd, J = 16.4, J = 8.5 Hz, 1 H, 4-H, minor), 5.17
(d, J = 5.6 Hz, 1 H, 4-H, major), 3.45–3.20 (m, 1 H, 1-H, minor),
3.15–2.96 (m, 2 H, 1-H, 3-H, major), 2.90–2.60 (m, 4 H, major +
minor), 2.50–2.00 (m, 6 H, major + minor), 2.00–1.60 (m, 3 H,
inseparable mixture of the bicyclic exo-8b and endo-9b as a color-
less solid (41 %; 53:47 dr, by 1H NMR). 1H NMR (360 MHz,
CDCl3): δ = 6.46 (d, J = 2.5 Hz, 1 H, 6-H or 7-H, minor), 6.40 (d,
J = 2.5 Hz, 1 H, 6-H or 7-H, major), 6.25 (d, J = 2.5 Hz, 1 H, 6-
H or 7-H, minor), 6.20 (d, J = 2.5 Hz, 1 H, 6-H or 7-H, major),
4.40–4.30 (m, 2 H, 4-H, major + minor), 3.50 (dd, J = 7.3, J =
2.9 Hz, 1 H, 1-H, minor), 3.38–3.30 (m, 2 H, 1-H, 5-H, major),
major + minor), 1.21 (s, 9 H, tBu, minor), 1.00 (s, 9 H, tBu, major) 3.26–3.23 (m, 1 H, 5-H, minor), 3.21 (ddd, J = 15.5, J = 4.7, J =
ppm. 13C NMR (90 MHz, CDCl3): δ = 218.9 (major), 216.8
(minor), 177.5 (major + minor), 75.4 (major), 70.9 (minor), 45.9
(minor), 43.8 (major), 42.8 (major), 42.0 (minor), 40.9 (major), 37.7
(minor), 26.9 (minor), 26.8 (major), 23.1 (major), 22.3 (minor), 21.8
(major), 21.7 (major), 19.7 (minor), 18.1 (minor) ppm. IR (neat):
0.7 Hz, 1 H, 3-H, major), 3.05 (ddd, J = 17.4, J = 10.0, J = 1.2 Hz,
1 H, 3-H, minor), 2.35 (ddd, J = 17.3, J = 7.8, J = 1.5 Hz, 1 H, 3-
H, minor), 2.13–2.05 (m, 1 H, 3-H, major), 0.91 (s, 9 H, SitBu,
major), 0.88 (s, 9 H, SitBu, minor), 0.10 (s, 3 H, SiMe, minor), 0.08
(s, 3 H, SiMe, major), 0.07 (s, 6 H, SiMe, major + minor) ppm.
13C NMR (90 MHz, CDCl3): δ = 220.9 (major), 214.5 (minor),
141.8 (major), 141.2 (minor), 137.2 (minor), 131.8 (major), 68.1
(major), 66.1 (minor), 55.9 (minor), 53.9 (major), 53.7 (major), 49.0
(minor), 44.1 (major), 42.4 (minor), 25.6 (major + minor), 17.9
(major + minor), –4.8 (major + minor), –4.9 (major + minor) ppm.
ν = 2976, 1752 cm–1. MS: m/z = 200 [M + NH ]+. C H O
˜
4
11 18
2
(182.26): calcd. C 72.49, H 9.95; found C 72.13, H 9.86.
(4S)-4-(Methoxymethoxy)bicyclo[3.2.0]heptan-2-one
[exo-5e
(1R,5S) and endo-6e (1S,5R)]: By using 2e and ethene, according
to Procedure A, flash chromatography (hexanes/Et2O, 60:40) gave
an inseparable mixture of bicyclic products exo-5e and endo-6e as
IR (neat): ν = 3053, 1741 cm–1. HRMS: calcd. for C H O SiNa
˜
13 22
2
261.1287; found 261.1283.
1
1
a colorless oil (48%; 70:30 dr, by H NMR). H NMR (360 MHz,
CDCl3): δ = 4.66 (d, J = 3.0 Hz, 1 H, OCH2O, major), 4.64 (s, 2
H, OCH2O, minor), 4.60 (d, J = 3.0 Hz, 1 H, OCH2O, major), 4.35
(dt, J = 10.4, J = 7.9 Hz, 1 H, 4-H, minor), 4.21 (d, J = 5.4 Hz, 1
H, 4-H, major), 3.38 (s, 3 H, OCH3, minor), 3.35 (s, 3 H, OCH3,
major), 3.30–3.20 (m, 1 H, 1-H, minor), 3.17–3.07 (m, 1 H, 1-H,
major), 2.96 (dd, J = 18.4, J = 5.4 Hz, 1 H, 3-H, major), 2.90–2.73
(m, 2 H, major + minor), 2.68 (ddd, J = 18.0, J = 8.2, J = 1.2 Hz,
1 H, 3-H, minor), 2.60–2.10 (m, 6 H, major + minor), 1.95–1.75
(m, 4 H, major + minor) ppm. 13C NMR (90 MHz, CDCl3): δ =
220.3 (major), 217.9 (minor), 95.6 (minor), 94.5 (major), 77.9
(major), 74.4 (minor), 55.4 (major + minor), 46.4 (minor), 43.9
(major), 43.5 (major), 42.5 (minor), 41.1 (major), 38.4 (minor), 22.4
(3S)-3-(tert-Butyldimethylsilyloxy)octahydrocyclopenta[3,4]cyclobuta-
[1,2]cyclopenten-1(2H)-one [exo-8c (3aS,6bR) and endo-9c
(3aR,6bS)]: By using 7c, according to Procedure B, flash
chromatography (hexanes/Et2O, 95:5) gave two separate bicyclic
products (54:46 dr, by 1H NMR) as a colorless oil for exo-8c (22%)
and as colorless needles for endo-9c (19%). exo-8c: [α]2D0 = +215 (c
= 0.6, CHCl3). 1H NMR (360 MHz, CDCl3): δ = 4.47 (dt, J = 11.1,
J = 7.6 Hz, 1 H, 10-H), 3.12–3.03 (m, 1 H, 7-H), 2.80 (dd, J =
17.0, J = 11.0 Hz, 1 H, 9-H), 2.54–2.39 (m, 2 H, 6-H, 9-H), 2.34–
2.24 (m, 1 H, 1-H), 2.22–2.12 (m, 1 H, 2-H), 1.92–1.54 (m, 6 H, 3-
H, 4-H, 5-H), 0.91 (s, 9 H, SitBu), 0.07 (s, 3 H, SiMe), 0.07 (s, 3
H, SiMe) ppm. 13C NMR (90 MHz, CDCl3): δ = 217.4, 70.0, 51.1,
44.8, 44.1, 41.7, 34.8, 33.2 (2 C), 25.7, 24.6, 18.0, –4.8 ppm. IR
(minor), 21.8 (2C, major), 18.2 (minor) ppm. IR (neat): ν = 2947,
˜
(neat): ν = 2953, 1740 cm–1. HRMS: calcd. for C16H28O2SiNa
1736 cm–1. MS: m/z
= 171 [M +
H]+. HRMS: calcd. for
˜
303.1756; found 303.1759. endo-9c: M.p. 45 °C. [α]2D0 = –129 (c =
1.0, CHCl3). 1H NMR (360 MHz, CDCl3): δ = 4.30 (d, J = 4.6 Hz,
1 H, 10-H), 2.92 (dd, J = 17.2, J = 4.6 Hz, 1 H, 9-H), 2.52–2.42
(m, 2 H, 1-H, 7-H), 2.30–2.10 (m, 3 H, 2-H, 6-H, 9-H), 1.95–1.45
(m, 6 H, 3-H, 4-H, 5-H), 0.84 (s, 9 H, SitBu), 0.04 (s, 6 H, SiMe2)
ppm. 13C NMR (90 MHz, CDCl3): δ = 220.0, 74.1, 48.5, 48.0, 45.9,
C9H14O3Na 193.0841; found 193.0845.
(4S)-4-(tert-Butyldimethylsilyloxy)-6,6,7,7-tetramethylbicyclo[3.2.0]-
heptan-2-one [exo-8a (1R,5S) and endo-9a (1S,5R)]: By using 7a,
according to Procedure B, flash chromatography (CH2Cl2/MeOH,
1
9:1) gave two separable bicyclic products (60:40 dr, by H NMR)
as a colorless oil for exo-8a (27%) and as colorless needles for endo-
9a (18%). exo-8a: [α]2D0 = +168 (c = 1.05, CHCl3). 1H NMR
(360 MHz, CDCl3): δ = 4.58 (dt, J = 9.6, J = 7.9 Hz, 1 H, 4-H),
2.74 (t, J = 7.6 Hz, 1 H, 3-H), 2.71 (dd, J = 19.1, J = 10.1 Hz, 1
H, 1-H), 2.58 (ddd, J = 19.6, J = 9.4, J = 1.3 Hz, 1 H, 5-H), 2.31
(d, J = 7.9 Hz, 1 H, 3-H), 1.25 (s, 3 H, CH3), 1.17 (s, 3 H, CH3),
1.10 (s, 3 H, CH3), 0.93 (s, 3 H, CH3), 0.91 (s, 9 H, SitBu), 0.08 (s,
3 H, SiMe), 0.06 (s, 3 H, SiMe) ppm. 13C NMR (90 MHz, CDCl3):
δ = 218.5, 71.3, 56.0, 48.5, 48.1, 41.7, 39.4, 27.7, 27.6, 25.8, 22.6,
40.1, 39.4, 33.1, 32.9, 25.7, 24.6, 18.0, –4.8 ppm. IR (neat): ν =
˜
2951, 1741 cm–1. HRMS: calcd. for C16H28O2SiNa 303.1756; found
303.1754.
(4S)-4-(tert-Butyldimethylsilyloxy)-6,7-dichlorobicyclo[3.2.0]heptan-
2-one [exo-8d (1R,5S) and endo-9d (1S,5R)]: By using 7d, according
to the general Procedure B, flash chromatography (hexanes/Et2O,
90:10) provided two fractions. The first (minor) one, endo-9d, was
obtained as a colorless oil (16%) and was a unique anti or syn
diastereomer. The second (major) one, exo-8d, was obtained as col-
orless needles (33%) and was an inseparable mixture of stereoiso-
20.2, 17.9, –4.9 ppm. IR (neat): ν = 2956, 1735 cm–1. HRMS: calcd.
˜
for C17H32O2SiNa 319.2069; found 319.2075. endo-9a: M.p. 84 °C.
1
1
mers at positions C-6 and C-7 (78:22 dr, by H NMR). exo-8d: H
NMR (360 MHz, CDCl3): δ = 4.79 (ddd, J = 6.5, J = 4.2, J =
2.5 Hz, 1 H, 4-H, major), 4.71 (ddd, J = 9.3, J = 6.5, J = 0.8 Hz,
1 H, 7-H, major), 4.56 (dd, J = 8.2, J = 6.8 Hz, 1 H, 4-H, minor),
4.50 (d, J = 5.0 Hz, 1 H, 7-H, minor), 4.14 (ddd, J = 6.4, J = 5.6,
J = 1.1 Hz, 1 H, 6-H, major), 4.06 (ddd, J = 6.8, J = 5.8, J =
1.1 Hz, 1 H, 6-H, minor), 3.34–3.22 (m, 2 H, 3-H, major + minor),
3.13–3.06 (m, 1 H, 3-H, major), 3.01–2.97 (m, 1 H, 3-H, minor),
2.94 (dd, J = 18.4, J = 6.4 Hz, 1 H, 1-H, major), 2.74 (dd, J =
18.7, J = 4.8 Hz, 1 H, 1-H, minor), 2.48–2.35 (m, 2 H, 5-H, major
+ minor), 0.87 (s, 9 H, SitBu, major), 0.86 (s, 9 H, SitBu, minor),
0.11 (s, 6 H, SiMe, major + minor), 0.09 (s, 6 H, SiMe, major +
minor) ppm. 13C NMR (90 MHz, CDCl3): δ = 214.5 (minor), 211.4
1
[α]2D0 = –145 (c = 1.05, CHCl3). H NMR (360 MHz, CDCl3): δ =
4.52–4.46 (m, 1 H, 4-H), 2.78 (dd, J = 19.5, J = 6.5 Hz, 1 H, 3-H),
2.62–2.55 (m, 1 H, 1-H), 2.46 (d, J = 8.3 Hz, 1 H, 5-H), 2.39–2.29
(m, 1 H, 3-H), 1.13 (s, 3 H, CH3), 1.12 (s, 3 H, CH3), 0.96 (s, 3 H,
CH3), 0.87 (s, 12 H, CH3, SitBu), 0.06 (s, 3 H, SiMe), 0.05 (s, 3 H,
SiMe) ppm. 13C NMR (90 MHz, CDCl3): δ = 220.1, 70.1, 53.8,
53.1, 51.4, 41.7, 39.6, 27.2, 27.0, 25.8, 21.1, 20.8, 17.9, –4.7 ppm.
IR (neat): ν = 2954, 1717 cm–1. HRMS: calcd. for C H O SiNa
˜
17 32
2
319.2069; found 319.2074.
(4S)-4-(tert-Butyldimethylsilyloxy)bicyclo[3.2.0]hept-6-en-2-one
[exo-8b (1R,5S) and endo-9b (1S,5R)]: By using 7b, according to
Procedure A, flash chromatography (hexanes/Et2O, 95:5) gave an
5958
www.eurjoc.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2009, 5953–5962